TRCT
EPIX

Tower Research Capital (TRC)’s ESSA Pharma EPIX Stock Holding History

Tower Research Capital (TRC)’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-27
Closed -$73 – 6011
2023
Q2 		$73 Buy
+27
New +$79 ﹤0.01% 5841
2023
Q1 		– Sell
-113
Closed – – 5918
2022
Q4 		$0 Sell
113
-16,647
-99% -$47.8K ﹤0.01% 5996
2022
Q3 		$30K Sell
16,760
-5,208
-24% -$13.7K ﹤0.01% 3596
2022
Q2 		$69K Buy
21,968
+21,513
+4,728% +$120K ﹤0.01% 2590
2022
Q1 		$3K Buy
455
+104
+30% +$914 ﹤0.01% 5362
2021
Q4 		$5K Sell
351
-6,539
-95% -$72.8K ﹤0.01% 5145
2021
Q3 		$55K Buy
+6,890
New +$110K ﹤0.01% 2874
2020
Q1 		– Sell
-89
Closed – – 3252
2019
Q4 		$0 Sell
89
-111
-56% -$516 ﹤0.01% 3748
2019
Q3 		$1K Buy
+200
New +$494 ﹤0.01% 3843
2018
Q4 		– Sell
-400
Closed -$1K – 3934
2018
Q3 		$1K Buy
400
+200
+100% +$669 ﹤0.01% 3577
2018
Q2 		$1K Buy
+200
New +$748 ﹤0.01% 3474
2017
Q2 		– Sell
-20
Closed -$1K – 2891
2017
Q1 		$1K Sell
20
-90
-82% -$4.3K ﹤0.01% 2780
2016
Q4 		$5K Buy
110
+21
+24% +$914 ﹤0.01% 3029
2016
Q3 		$5K Buy
89
+5
+6% +$267 ﹤0.01% 2537
2016
Q2 		$5K Buy
84
+15
+22% +$936 ﹤0.01% 3366
2016
Q1 		$4K Buy
69
+29
+73% +$1.89K ﹤0.01% 2873
2015
Q4 		$5K Hold
40
– – ﹤0.01% 2958
2015
Q3 		$5K Buy
+40
New +$5.58K ﹤0.01% 2786

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Tower Research Capital (TRC)'s EPIX Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of ESSA Pharma (EPIX) in Q3 2023, closing a stake of 27 shares — an estimated $73 sold.

Tower Research Capital (TRC) first reported a position in EPIX in Q3 2015 and held it in 18 quarters. The position peaked at $69K in Q2 2022. 36 funds tracked by Wall St. Rank hold EPIX as of Q3 2023.

  • Tower Research Capital (TRC) reported no remaining ESSA Pharma position as of Q3 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 27 ESSA Pharma shares in Q3 2023, an estimated $73.
  • Tower Research Capital (TRC) first reported a position in ESSA Pharma in Q3 2015 and held it in 18 quarters.
  • Tower Research Capital (TRC)'s ESSA Pharma position peaked at $69K in Q2 2022.
  • 36 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.